ESGCT – 2022 – Poster Presentation P432
Publications
October 11, 2022
Multiplex Deletion of Myeloid Antigens by Base Editing in Human Hematopoietic Stem and Progenitor Cells (HSPCs) Enables Potential for Next Generation Transplant for Acute Myeloid Leukemia (AML) Treatment
Platform
Presented by: John R. Lydeard, PhD – Discovery and Molecular Engineering – Vor Bio